Literature DB >> 11805724

International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring.

David W Holt1, Victor W Armstrong, Andrea Griesmacher, Raymond G Morris, Kimberly L Napoli, Leslie M Shaw.   

Abstract

Issues surrounding the measurement and interpretation of immunosuppressive drug concentrations have been summarized in a number of consensus documents. The Scientific Division of the International Federation of Clinical Chemistry has formed a working group in collaboration with the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. This paper sets out the goals of the working group in light of the developments that have occurred in the field of immunosuppressive drug monitoring since the publication of the last consensus documents.

Mesh：

Substances：

Year:  2002        PMID： 11805724     DOI： 10.1097/00007691-200202000-00011

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN： 0163-4356            Impact factor:   3.681


  13 in total

1.  Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.

Authors:  Marie Antignac; Jean Sebastien Hulot; Emmanuel Boleslawski; Laurent Hannoun; Yvan Touitou; Robert Farinotti; Philippe Lechat; Saïk Urien
Journal:  Eur J Clin Pharmacol       Date:  2005-07-01       Impact factor: 2.953

2.  Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients.

Authors:  Marie Antignac; Christine Fernandez; Benoît Barrou; Mariona Roca; Jean-Louis Favrat; Saïk Urien; Robert Farinotti
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-24       Impact factor: 2.441

Review 3.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  A Nucleic Acid Nanostructure Built through On-Electrode Ligation for Electrochemical Detection of a Broad Range of Analytes.

Authors:  Subramaniam Somasundaram; Christopher J Easley
Journal:  J Am Chem Soc       Date:  2019-07-09       Impact factor: 15.419

5.  Cyclosporin therapeutic drug monitoring--an established service revisited.

Authors:  Raymond G Morris
Journal:  Clin Biochem Rev       Date:  2003-05

6.  Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS.

Authors:  Touraj Shokati; Nicholas Bodenberger; Holly Gadpaille; Björn Schniedewind; Alexander A Vinks; Wenlei Jiang; Rita R Alloway; Uwe Christians
Journal:  J Vis Exp       Date:  2015-11-08       Impact factor: 1.355

7.  Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients.

Authors:  Marie Antignac; Benoit Barrou; Robert Farinotti; Philippe Lechat; Saïk Urien
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335

8.  Efficacy, Safety, and Practicality of Tacrolimus Monitoring after Bone Marrow Transplant: Assessment of a Change in Practice.

Authors:  Jacky Cheung; Jason Wentzell; Melanie Trinacty; Pierre Giguère; Priya Patel; Natasha Kekre; Tiffany Nguyen
Journal:  Can J Hosp Pharm       Date:  2020-02-01

9.  Estimation of Abbreviated Cyclosporine A Area under the Concentration-Time Curve in Allogenic Stem Cell Transplantation after Oral Administration.

Authors:  Hanene Eljebari; Nadia Ben Fradj; Issam Salouage; Emna Gaies; Sameh Trabelsi; Nadia Jebabli; Mohamed Lakhal; Tarek Ben Othman; Anis Kouz
Journal:  J Transplant       Date:  2011-10-26

Review 10.  Overview of therapeutic drug monitoring.

Authors:  Ju Seop Kang; Min Ho Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.